Chen et al. synthesized CQD-KD1, a CQDs conjugated with a recombinant st14 inhibitor (KD1) to target MCF-7 breast cancer cells, which are known for overexpressing st14 on the cell surface [66]. Here, ST14 is linked to breast carcinoma.